WSCTS is not responsible for work not submitted by the submission deadline.
No new submissions may be added to the system after the posted deadline.
Submissions must be submitted in their final form by the deadline to be considered for presentation.
The submission deadline will be on June 15, 2023.
Abstracts will be published exactly as submitted. Proofread carefully to avoid errors.
An author may not revise or resubmit a submission in order to make corrections after the submission deadline. Rather, the submission may be withdrawn or, if accepted, the error may be revised and indicated during the presentation.
All expenses (e.g., registration, airfare, lodging, etc.) associated with the submission and presentation are the presenter's responsibility.
Submission of an abstract constitutes a commitment by the author(s) to present if accepted. Failure to register for the activity and present the accepted work, if not justified, will jeopardize future acceptance of abstracts by the WSCTS, LACES, and SBSCVS.
ABSTRACT SUBMISSION POLICIES
There is no limit to the number of abstracts an author may submit.
There must be a minimum of two (2) authors on the abstract submission.
There is no maximum number of authors that may be listed on the submission.
All co-authors must be listed on the abstract submission.
Authors do not need to be WSCTS members to participate.
Additions or deletions of author names are not permitted after the submission deadline.
If an author's name appears on more than one submission, it must be identical on each submission.
The presenting author must be one of the co-authors listed on the submitted abstract.
Suppose an author has more than one submission accepted for presentation. In that case, he/she may only present one submission personally and must assign one of his/her co-authors to present any subsequent abstracts.
The submitting author must notify all co-authors that this work has been submitted
All abstracts must be structured using the following four section headings or they will not be considered. The labels must be submitted in bold font. Please see the sample abstract at the end of this document.
Objective: The hypothesis tested or the purpose of the study.
Methods: Details of the study design or protocol.
Results: Results of the study with appropriate statistical inferences.
Conclusions: Clinical importance and potential significance of findings.
The text of your abstract must be less than 3,500 characters, including spaces (title, authors and institutions will not be counted).
Submissions containing identical or nearly identical data submitted from the same institution and/or authors will be disqualified.
Authors should not split data to create several abstracts from one study, clinical trial, and/or experiment. If splitting is judged to have occurred, priority scores of all related abstracts will suffer, and abstracts may be disqualified.
The use of tables or graphics are encouraged if they are relevant to the research submitted. You may include one table or one figure within your submission. Please be mindful that tables and graphics, if the quality submitted is poor, will appear badly in electronic publications.
Abstracts should clearly reflect the content of the completed paper.
The abstract should not use abbreviations, which are not commonly accepted within the cardiothoracic surgical literature. Commonly accepted abbreviations within the cardiothoracic surgical literature will be accepted (i.e. - CABG, FEV1, GERD, CPR). However, other medical acronyms (i.e. - bronchiolitis obliterans syndrome (BOS)) should be first spelled out.
When percentages are used, the absolute numbers from which the fractions are derived must also be stated.
The abstract language is English.
*Abstract submissions may be disqualified, sanctioned, and/or removed from the program if the policies listed above are not followed.
AUTHORS’ CONSENT AND WAIVER OF CLAIMS FOR ABSTRACT SUBMISSIONS
Each author agrees they have read and consent to all rules and regulations as outlined, pertaining to the submission of abstracts. It is the responsibility of the author to be in accordance with these rules and regulations during all parts of, but not limited to, the abstract submission and review process.
Upon submission, authors waive any and all claims against the WSCTS and any reviewer and/or Planning Committee Member pertaining to, but not limited to, the abstract submission and review process.
After the submission deadline, all abstracts are considered Complete and will be forwarded to review.
Submissions with an Incomplete status after the submission deadline will not be considered for presentation.
Submitted abstracts are peer-reviewed by a panel of graders. Grading is blinded and selections for presentation are based solely on scientific merit.
Abstract notifications will be distributed to the submitting author via email. It is the responsibility of the submitting author to notify all co-authors of the decision.
All abstracts presented at WSCTS activities must conform to the eligibility criteria listed above.
All presentations and questions-and-answer periods will be in English (unless otherwise instructed). If presenters need assistance in understanding or responding to questions in English, they are encouraged to have a member of their research group assist them.
Each presenting author is required to be registered for the meeting. There should be one registration per abstract submitted. Failure to comply to this will disqualify the abstract.
Disclosure information collected during the submission process will be published in WSCTS’s final program materials. To be in compliance with this policy, presenting authors must disclose at the beginning of their presentation.
Any additional or revised guidelines for abstract presentation will be provided to presenting authors of accepted abstracts in their notification email.